Elevation Oncology, Inc. NASDAQ:ELEV

Founder-led company

Elevation Oncology stock price today

$0.377
-0.21
-36.5%
Financial Health
0
1
2
3
4
5
6
7
8
9

Elevation Oncology stock price monthly change

-79.38%
month

Elevation Oncology stock price quarterly change

-79.38%
quarter

Elevation Oncology stock price yearly change

+8.20%
year

Elevation Oncology key metrics

Market Cap
33.57M
Enterprise value
31.21M
P/E
-0.47
EV/Sales
N/A
EV/EBITDA
-0.32
Price/Sales
N/A
Price/Book
0.97
PEG ratio
N/A
EPS
-1.04
Revenue
N/A
EBITDA
-38.53M
Income
-39.35M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Elevation Oncology stock price history

Elevation Oncology stock forecast

Elevation Oncology financial statements

Elevation Oncology, Inc. (NASDAQ:ELEV): Profit margin
Jun 2023 0 -10.11M
Sep 2023 0 -10.63M
Dec 2023 58K -7.89M -13618.97%
Mar 2024 0 -10.70M
Elevation Oncology, Inc. (NASDAQ:ELEV): Analyst Estimates
Mar 2024 0 -10.70M
Sep 2025 0 -8.48M
Oct 2025 0 -11.30M
Dec 2025 0 -11.85M
  • Analysts Price target

  • Financials & Ratios estimates

Elevation Oncology, Inc. (NASDAQ:ELEV): Earnings per share (EPS)
2022-08-04 -0.93886 -0.86
2022-11-03 -2.14862 -1.67
2023-03-09 -0.86043 -0.82
Elevation Oncology, Inc. (NASDAQ:ELEV): Debt to assets
Jun 2023 110370000 38.18M 34.6%
Sep 2023 99975000 37.55M 37.57%
Dec 2023 89091000 34.28M 38.48%
Mar 2024 108961000 33.14M 30.42%
Elevation Oncology, Inc. (NASDAQ:ELEV): Cash Flow
Jun 2023 -13.81M 16.5M 47.73M
Sep 2023 -13.35M -38.11M 27K
Dec 2023 -12.18M 6.56M -2K
Mar 2024 -9.57M 20.7M 30.25M

Elevation Oncology alternative data

Elevation Oncology, Inc. (NASDAQ:ELEV): Employee count
Aug 2023 33
Sep 2023 33
Oct 2023 33
Nov 2023 33
Dec 2023 33
Jan 2024 33
Feb 2024 33
Mar 2024 29
Apr 2024 29
May 2024 29
Jun 2024 29
Jul 2024 29

Elevation Oncology other data

26.71% -35.22%
of ELEV is owned by hedge funds
6.21M -8.20M
shares is hold by hedge funds

Elevation Oncology, Inc. (NASDAQ:ELEV): Insider trades (number of shares)
Period Buy Sel
Jun 2021 1625000 0
May 2022 0 702737
Transaction Date Insider Security Shares Price per share Total value Source
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Common Stock 12,563 N/A N/A
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Restricted Stock Unit 12,563 N/A N/A
Option
FURLONG TAMMY officer: CHIEF FINANCIAL OFFICER
Restricted Stock Unit 300 N/A N/A
Option
FURLONG TAMMY officer: CHIEF FINANCIAL OFFICER
Common Stock 300 N/A N/A
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Common Stock 12,562 N/A N/A
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Restricted Stock Unit 12,562 N/A N/A
Option
FURLONG TAMMY officer: CHIEF FINANCIAL OFFICER
Restricted Stock Unit 300 N/A N/A
Option
FURLONG TAMMY officer: CHIEF FINANCIAL OFFICER
Common Stock 300 N/A N/A
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Common Stock 12,562 N/A N/A
Option
FERRA JOSEPH J JR director, officer: CHIEF EXECUT..
Restricted Stock Unit 12,562 N/A N/A
Insider Compensation
Dr. Shawn M. Leland Pharm.D., R.Ph. (1984) Founder, Pres, Chief Executive Officer & Director
$452,740
Thursday, 12 December 2024
prnewswire.com
prnewswire.com
Thursday, 5 December 2024
prnewswire.com
Tuesday, 26 November 2024
prnewswire.com
Wednesday, 6 November 2024
prnewswire.com
Thursday, 10 October 2024
zacks.com
Wednesday, 9 October 2024
gurufocus.com
Monday, 23 September 2024
prnewswire.com
Tuesday, 3 September 2024
prnewswire.com
Friday, 9 August 2024
seekingalpha.com
Tuesday, 6 August 2024
benzinga.com
prnewswire.com
prnewswire.com
Thursday, 27 June 2024
prnewswire.com
Tuesday, 7 May 2024
PRNewsWire
Friday, 8 March 2024
InvestorPlace
Tuesday, 5 March 2024
InvestorPlace
PRNewsWire
Wednesday, 28 February 2024
PRNewsWire
Friday, 23 February 2024
InvestorPlace
Tuesday, 5 September 2023
PRNewsWire
Friday, 9 June 2023
InvestorPlace
Tuesday, 30 May 2023
MarketBeat
Friday, 26 May 2023
InvestorPlace
Thursday, 25 May 2023
PennyStocks
Thursday, 23 March 2023
Zacks Investment Research
Thursday, 26 January 2023
MarketBeat
Thursday, 26 May 2022
PRNewsWire
Wednesday, 25 May 2022
PennyStocks
Benzinga
  • What's the price of Elevation Oncology stock today?

    One share of Elevation Oncology stock can currently be purchased for approximately $0.38.

  • When is Elevation Oncology's next earnings date?

    Unfortunately, Elevation Oncology's (ELEV) next earnings date is currently unknown.

  • Does Elevation Oncology pay dividends?

    No, Elevation Oncology does not pay dividends.

  • How much money does Elevation Oncology make?

    Elevation Oncology has a market capitalization of 33.57M. Elevation Oncology made a loss 45.7M US dollars in net income (profit) last year or -$0.82 on an earnings per share basis.

  • What is Elevation Oncology's stock symbol?

    Elevation Oncology, Inc. is traded on the NASDAQ under the ticker symbol "ELEV".

  • What is Elevation Oncology's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Elevation Oncology?

    Shares of Elevation Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Elevation Oncology's key executives?

    Elevation Oncology's management team includes the following people:

    • Dr. Shawn M. Leland Pharm.D., R.Ph. Founder, Pres, Chief Executive Officer & Director(age: 41, pay: $452,740)
  • Is Elevation Oncology founder-led company?

    Yes, Elevation Oncology is a company led by its founder Dr. Shawn M. Leland Pharm.D., R.Ph..

  • How many employees does Elevation Oncology have?

    As Jul 2024, Elevation Oncology employs 29 workers.

  • When Elevation Oncology went public?

    Elevation Oncology, Inc. is publicly traded company for more then 4 years since IPO on 25 Jun 2021.

  • What is Elevation Oncology's official website?

    The official website for Elevation Oncology is elevationoncology.com.

  • Where are Elevation Oncology's headquarters?

    Elevation Oncology is headquartered at 888 Seventh Avenue, New York, NY.

  • How can i contact Elevation Oncology?

    Elevation Oncology's mailing address is 888 Seventh Avenue, New York, NY and company can be reached via phone at +7 163711125.

Elevation Oncology company profile:

Elevation Oncology, Inc.

elevationoncology.com
Exchange:

NASDAQ

Full time employees:

29

Industry:

Biotechnology

Sector:

Healthcare

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

888 Seventh Avenue
New York, NY 10106

CIK: 0001783032
ISIN: US28623U1016
CUSIP: 28623U101